首页|SNHG 1在肿瘤中的研究进展

SNHG 1在肿瘤中的研究进展

扫码查看
SNHG1在多种癌症中异常表达,且作为肿瘤驱动因子参与细胞的增殖、周期、凋亡、迁移和侵袭等多个过程的调控。SNHG1有潜力成为肿瘤诊断、治疗和预后评估的新生物标志物和治疗靶点。本文综述SNHG1的发病机制及其在肿瘤发生、发展中作用的最新研究进展,以期为肿瘤的早期诊断和早期治疗提供新的依据和方向。
Research progress of SNHG1 in tumor
SNHG1 is aberrantly expressed in a variety of cancers and participates as a tumor driver in the regulation of multiple processes such as cell proliferation,cycling,apoptosis,migration,and invasion,etc.SNHG1 has potential to become a new biomarker and therapeutic target for tumor diagnosis,treatment,and prognostic assessment.This article reviews latest research progress on the pathogenesis of SNHG1 and the role of SNHG1 in tumor genesis and development,with a view to providing a new basis and direction for early diagnosis and early treatment of tumors.

TumorSNHG1Long non-coding RNAResearch progress

孔妮、马红、罗洞波

展开 >

新疆医科大学附属肿瘤医院胸外二科,新疆乌鲁木齐 830011

新疆医科大学基础医学院,新疆乌鲁木齐 830017

肿瘤 SNHG1 长链非编码RNA 研究进展

省部共建中亚高发病成因与防治国家重点实验室开放课题基金项目

SKL-HIDCA-2022-17

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(19)